Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-fluoro-met
2. Ds425rq8sx
3. 2698331-35-8
4. Refchem:1080124
5. Chembl4873240
6. Bretisilocin [inn]
7. Chembl5028766
8. Schembl24243693
9. Schembl29904441
10. Bdbm693491
11. 5-fluoro-n-methyl-n-ethyltryptamine
12. Bdbm50578374
13. Us20240286998, Compound 12
14. N-ethyl-5-fluoro-n-methyl-1h-indole-3-ethanamine
15. 1h-indole-3-ethanamine, N-ethyl-5-fluoro-n-methyl-
16. N-ethyl-2-(5-fluoro-1h-indol-3-yl)-n- Methylethan-1-amine
17. N-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine
| Molecular Weight | 220.29 g/mol |
|---|---|
| Molecular Formula | C13H17FN2 |
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 19 |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 222 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
35
PharmaCompass offers a list of Bretisilocin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bretisilocin manufacturer or Bretisilocin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bretisilocin manufacturer or Bretisilocin supplier.
A Bretisilocin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bretisilocin, including repackagers and relabelers. The FDA regulates Bretisilocin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bretisilocin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bretisilocin supplier is an individual or a company that provides Bretisilocin active pharmaceutical ingredient (API) or Bretisilocin finished formulations upon request. The Bretisilocin suppliers may include Bretisilocin API manufacturers, exporters, distributors and traders.
Bretisilocin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bretisilocin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bretisilocin GMP manufacturer or Bretisilocin GMP API supplier for your needs.
A Bretisilocin CoA (Certificate of Analysis) is a formal document that attests to Bretisilocin's compliance with Bretisilocin specifications and serves as a tool for batch-level quality control.
Bretisilocin CoA mostly includes findings from lab analyses of a specific batch. For each Bretisilocin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bretisilocin may be tested according to a variety of international standards, such as European Pharmacopoeia (Bretisilocin EP), Bretisilocin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bretisilocin USP).
